Skip to content Skip to footer
AI in Evidence Generation

How HTA Agencies Are Evaluating AI in Evidence Generation

As AI rapidly reshapes the evidence landscape, health technology assessment (HTA) bodies are beginning to define clear expectations for its use in submissions. At CapeStart, we work closely with life sciences clients navigating these changes—especially those integrating GenAI into literature reviews, RWE generation, economic modeling, Joint Clinical Assessment (JCA) support, Clinical Evaluation Reports (CERs), Patient…

Read More

ROI of GenAI

How MadeAi™ Uses GenAI-Aided Review & AI as Reviewer to Beat Manual SLR Solutions

In today’s fast-paced life sciences environment, literature reviews are critical—but they’re also time-consuming, labor-intensive, and increasingly expected to support regulatory, HEOR, and market access submissions while maintaining full transparency and traceability.  While traditional platforms offer useful automation features, most are either rules-based classifiers or structured workflow tools, limiting their adaptability and explainability. That’s where MadeAi™…

Read More

AI’s Biggest Wins

AI’s Biggest Wins: Three Core Business Areas Benefiting the Most

Across industries, businesses are turning to AI to address pressing challenges, drive innovation, and improve efficiency. According to CapeStart’s Life Science AI Research Report, organizations are increasingly identifying specific areas where AI can deliver the greatest value. By focusing on key business functions, companies aim to unlock new opportunities, streamline operations, and enhance their impact…

Read More